Skip to main navigation Skip to search Skip to main content

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes

  • Guillermo Garcia-Manero
  • , Guillermo Montalban-Bravo
  • , Jesus G. Berdeja
  • , Yasmin Abaza
  • , Elias Jabbour
  • , James Essell
  • , Roger M. Lyons
  • , Farhad Ravandi
  • , Michael Maris
  • , Brian Heller
  • , Amy E. DeZern
  • , Sunil Babu
  • , David Wright
  • , Bertrand Anz
  • , Ralph Boccia
  • , Rami S. Komrokji
  • , Philip Kuriakose
  • , James Reeves
  • , Mikkael A. Sekeres
  • , Hagop M. Kantarjian
    • Richard Ghalie, Gail J. Roboz

Research output: Contribution to journal › Article › peer-review

59   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry